drugset / Trial / NCT00230698
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
RandomizedParallel-groupDouble-blindTreatment
Summary
The purposes of this study are (1) to compare the effectiveness of two doses of topiramate and (2) to assess the safety of topiramate alone in the treatment of pediatric and adult patients with recently diagnosed epilepsy characterized by partial-onset seizures.
Timeline
- Start
- 1995-11
- Primary completion
- —
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 24 mg/kg | Oral |
| Subject | Topiramate | Small molecule | 25 mg | Oral |
| Subject | Topiramate | Small molecule | 50 mg | Oral |
| Subject | Topiramate | Small molecule | 200 mg | Oral |
| Subject | Topiramate | Small molecule | 500 mg | Oral |
| Subject | Topiramate | Small molecule | 1600 mg | Oral |